Cargando…
Coronaviruses pandemics: Can neutralizing antibodies help?
For the first time in Homo sapiens history, possibly, most of human activities is stopped by coronavirus disease 2019 (COVID-19). Nearly eight billion people of this world are facing a great challenge, maybe not “to be or not to be” yet, but unpredictable. What happens to other major pandemics in th...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243778/ https://www.ncbi.nlm.nih.gov/pubmed/32450171 http://dx.doi.org/10.1016/j.lfs.2020.117836 |
_version_ | 1783537467761098752 |
---|---|
author | Tong, Phuoc-Bao-Viet Lin, Li-Yun Tran, Tuan Hiep |
author_facet | Tong, Phuoc-Bao-Viet Lin, Li-Yun Tran, Tuan Hiep |
author_sort | Tong, Phuoc-Bao-Viet |
collection | PubMed |
description | For the first time in Homo sapiens history, possibly, most of human activities is stopped by coronavirus disease 2019 (COVID-19). Nearly eight billion people of this world are facing a great challenge, maybe not “to be or not to be” yet, but unpredictable. What happens to other major pandemics in the past, and how human beings went through these hurdles? The human body is equipped with the immune system that can recognize, respond and fight against pathogens such as viruses. Following the innate response, immune system processes the adaptive response by which each pathogen is encoded and recorded in memory system. The humoral reaction containing cytokines and antibodies is expected to activate when the pathogens come back. Exploiting this nature of body protection, neutralizing antibodies have been investigated. Learning from past, in parallel to SARS-CoV-2, other coronaviruses SARS-CoV and MERS-CoV who caused previous pandemics, are recalled in this review. We here propose insights of origin and characteristics and perspective for the future of antibodies development. |
format | Online Article Text |
id | pubmed-7243778 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-72437782020-05-22 Coronaviruses pandemics: Can neutralizing antibodies help? Tong, Phuoc-Bao-Viet Lin, Li-Yun Tran, Tuan Hiep Life Sci Article For the first time in Homo sapiens history, possibly, most of human activities is stopped by coronavirus disease 2019 (COVID-19). Nearly eight billion people of this world are facing a great challenge, maybe not “to be or not to be” yet, but unpredictable. What happens to other major pandemics in the past, and how human beings went through these hurdles? The human body is equipped with the immune system that can recognize, respond and fight against pathogens such as viruses. Following the innate response, immune system processes the adaptive response by which each pathogen is encoded and recorded in memory system. The humoral reaction containing cytokines and antibodies is expected to activate when the pathogens come back. Exploiting this nature of body protection, neutralizing antibodies have been investigated. Learning from past, in parallel to SARS-CoV-2, other coronaviruses SARS-CoV and MERS-CoV who caused previous pandemics, are recalled in this review. We here propose insights of origin and characteristics and perspective for the future of antibodies development. Elsevier Inc. 2020-08-15 2020-05-22 /pmc/articles/PMC7243778/ /pubmed/32450171 http://dx.doi.org/10.1016/j.lfs.2020.117836 Text en © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Tong, Phuoc-Bao-Viet Lin, Li-Yun Tran, Tuan Hiep Coronaviruses pandemics: Can neutralizing antibodies help? |
title | Coronaviruses pandemics: Can neutralizing antibodies help? |
title_full | Coronaviruses pandemics: Can neutralizing antibodies help? |
title_fullStr | Coronaviruses pandemics: Can neutralizing antibodies help? |
title_full_unstemmed | Coronaviruses pandemics: Can neutralizing antibodies help? |
title_short | Coronaviruses pandemics: Can neutralizing antibodies help? |
title_sort | coronaviruses pandemics: can neutralizing antibodies help? |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243778/ https://www.ncbi.nlm.nih.gov/pubmed/32450171 http://dx.doi.org/10.1016/j.lfs.2020.117836 |
work_keys_str_mv | AT tongphuocbaoviet coronavirusespandemicscanneutralizingantibodieshelp AT linliyun coronavirusespandemicscanneutralizingantibodieshelp AT trantuanhiep coronavirusespandemicscanneutralizingantibodieshelp |